Virtual FDA Mock Inspections Readiness
Inspection-Realistic Virtual Assessments Built Around FDA Enforcement Behavior
Evaluate What FDA Will See, Ask, and Cite Before They Do
ComplyFDA delivers virtual FDA mock inspections and video-based reviews that identify inspection risk before it results in Form 483 observations or enforcement action.
FDA inspections are no longer limited to on-site walkthroughs. Inspectors now evaluate quality systems, facilities, and operations through a combination of live video, document requests, and focused interviews. Organizations that rely only on traditional readiness models often miss critical risks that surface during virtual or hybrid evaluations.
ComplyFDA delivers virtual FDA mock inspections, remote inspection readiness reviews, and video-based assessments designed to reflect how FDA investigators actually evaluate pharmaceutical, medical device, and biologics research and development environments today. Using secure video walkthroughs, recorded facility footage, and targeted document review, our experts assess real operations, not just written procedures.
These engagements are built to identify inspection exposure early, before it results in Form 483 observations, warning letters, or delayed development milestones. Clients receive prioritized, inspection-aligned findings and clear remediation guidance grounded in current FDA enforcement trends, not theoretical compliance.
Whether you are preparing for a first FDA inspection, scaling R&D into clinical or commercial manufacturing, transitioning quality systems, or responding to internal or external risk signals, ComplyFDA provides fast, defensible insight without disrupting operations or requiring on-site presence.
This is inspection based on current and evolving FDA inspection methodology.
How ComplyFDA Evaluates Inspection Risk Virtually
Inspection-Ready Quality Planning
Evaluate quality planning as FDA will assess it, not how it is documented. We review design controls, process readiness, and quality system execution using video walkthroughs and targeted records to identify inspection exposure early.
FDA Risk Exposure Identification
Identify and prioritize quality and operational risks most likely to result in Form 483 observations. Findings are ranked using current FDA citation trends to focus remediation where enforcement risk is highest.
Virtual Inspection Expertise
Work directly with experienced FDA inspection readiness professionals who evaluate your operations through secure video review, live walkthroughs, and focused interviews, without disrupting site activities.
Inspection-Realistic Virtual Reviews Aligned to FDA Enforcement Expectations
Expert-Led Virtual FDA Mock Inspections and Inspection Readiness Reviews
FDA inspections increasingly rely on targeted document review, focused interviews, and real-time observation of operations through live or recorded video. Organizations that prepare only for traditional on-site inspections often overlook gaps that become visible when FDA evaluates how work is actually performed.
ComplyFDA’s virtual mock inspections and inspection readiness reviews provide an efficient way to assess FDA-facing risk without disrupting site operations. Using secure video walkthroughs, recorded footage of facilities and processes, and focused quality system review, our experts evaluate execution against current FDA inspection expectations.
The outcome is a clear, inspection-aligned understanding of where risk exists, why it matters, and what actions are required to reduce exposure before an inspection occurs.
